This study was conducted to investigate any potential reaction between losartan and hydrochlorothiazide.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
18
Heart rate
Time frame: Participants will be followed for the duration of study, an expected average of 5 weeks.
Blood pressure
Time frame: Participants will be monitored for the duration of study, an expected average of 5 weeks.
Pharmacokinetic parameter such as Cmax of losartan and hydrochlorothiazide
Time frame: At the end of the study, after collection of all blood samples, an expected average of 4 weeks
Pharmacokinetic parameter such as AUC of losartan and hydrochlorothiazide
Time frame: At the end of the study, after collection of all blood samples, an expected average of 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.